Benefits
Wound Healing and Scar Improvement (Topical Use, Not Oral)
TECA (Total Triterpenic Fraction of Centella Asiatica) has well-established wound healing effects. This is a topical use: creams and gels are applied to the skin, not swallowed. Trials of topical TECA show improved wound healing and reduced scarring. These skin-applied results do not transfer to an oral capsule.
Venous Circulation and Leg Oedema Support
Multiple European trials show gotu kola extract (TECA, Centellase®) improves CVI symptoms — leg heaviness, edema, capillary fragility. Mechanism: collagen synthesis support, microcirculation improvement.
Anxiety and Cognitive Support
A single 12 g oral dose lowered the acoustic startle response (an anxiety marker) in healthy volunteers, not in people diagnosed with an anxiety disorder. A separate 2 month trial in 28 healthy older adults found better working memory only at the highest dose (750 mg/day), with modest mood gains. Both trials are small, so the anxiety and cognition evidence is preliminary.
Skin Healing Support (Topical Use, Not Oral)
This evidence is from TECA applied to the skin, not from oral supplements. Topical products are used to support healing of damaged skin and appear in some scar-care products. Swallowed capsules have not been shown to do this.
Stretch Mark Support (Topical Creams, Not Oral)
Centella creams are applied to the skin during and after pregnancy for stretch marks. A trial of the topical cream showed fewer stretch marks. This is a skin-applied result, not an outcome from swallowing gotu kola.
Mechanism of action
Collagen Synthesis Stimulation
Triterpenes (especially asiaticoside, madecassoside) stimulate fibroblast proliferation and collagen type I and III synthesis. Foundational mechanism for wound healing, scar improvement, and connective tissue applications.
Microcirculation Enhancement
Improves capillary integrity and microcirculation — basis for venous insufficiency and capillary fragility applications.
GABA Modulation (Anxiolytic)
Some triterpenes modulate GABA-A receptors — basis for anxiolytic effects. Modest activity.
Neurotrophic Effects (BDNF)
Animal studies show centella increases BDNF and neurogenesis — basis for cognitive applications. Mechanism for theoretical anti-aging brain effects.
Antioxidant / Anti-Inflammatory
Direct antioxidant activity plus anti-inflammatory effects via NF-κB modulation. Contributes to multiple applications.
Clinical trials
Multiple European clinical trials of TECA (60-120 mg/day) for chronic venous insufficiency.
CVI patients across multiple trials.
Significant improvements in symptoms (leg heaviness, edema, pain) and microcirculation parameters. Small oral TECA trials show reduced leg oedema and improved microcirculation; the independent 2020 Cochrane review rates the phlebotonic class effect on swelling as only slight.
Single-dose clinical trial of gotu kola (12 g dried plant) vs placebo on acoustic startle response in healthy subjects.
40 healthy subjects.
Significantly attenuated startle response (anxiolytic biomarker) vs placebo. Suggested anxiolytic effects without sedation. Single-dose; limited generalizability.